Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Defactinib in Combination with Mitotane Can Be an Effective Treatment in Human Adrenocortical Carcinoma

International Journal of Molecular Sciences(2025)10.3390/ijms26136539Source: DataRank Database

Defactinib in Combination with Mitotane Can Be an Effective Treatment in Human Adrenocortical Carcinoma is a research paper published in International Journal of Molecular Sciences (2025). On theSindex it has a DataRank of 0.104. It has been cited 1 time.

N/A

0.104DataRank · unranked

Scored on demand from live citation data

1 citations

Download PDF

Cite:

Linked data & code

cellosaurus go nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.14)OA: goldTopics (42)IDs (PubMed, PMC, OpenAlex)Annotations (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.104

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (19)

Lőrinc Pongor,Lilla Krokker,Borbála Szabó,Katalin Dezső ORCID,Titanilla Dankó

Live enrichment

PubMed:40650315 PMC:PMC12249900 OpenAlex:https://openalex.org/W4412070750

Hungarian Scientific Research Grant of the National Research, Development and Innovation (NRDI) Office Fund of the Ministry of Culture and Innovation under the National Laboratories Program (National Tumour Biology Laboratory

Grant: 2022-2.1.1-NL-2022-00010

Grant: TKP2021-EGA/TKP2021-NVA/TKP2021-NKTA, MOLORKIV

Grant: NRDI NKFI-FK135065

Grant: ÚNKP-23-5-SE-4

Grant: BO/00092/21

European Commission

Grant: 739593

Establishing the Hungarian Center of Excellence for Molecular Medicine in partnership with EMBL

FWCI

1.14

Citation Percentile

0.8%

Citation Trend

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1422-0067/26/13/6539/pdf?version=1751895014

publisherhttps://www.mdpi.com/1422-0067/26/13/6539/pdf?version=1751895014

publisherhttps://www.mdpi.com/1422-0067/26/13/6539/pdf

journalhttps://doi.org/10.3390/ijms26136539

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40650315

Fields of Study

Adrenal and Paraganglionic TumorsCancer, Hypoxia, and MetabolismGlioma Diagnosis and Treatment03 medical and health sciences0302 clinical medicine

MeSH Terms

Adrenal Cortex NeoplasmsAnimalsAntineoplastic Combined Chemotherapy ProtocolsFemaleHumansMitotaneGene Expression Regulation, NeoplasticAdrenocortical CarcinomaXenograft Model Antitumor AssaysCell Line, TumorMiceFocal Adhesion Kinase 1

Keywords

MitotaneAdrenocortical carcinomaOncologyMedicineCarcinomaAdrenal cortexInternal medicineCancer researchTargeted TherapyDrug Repurposing3d ModelAdrenocortical CancerDefactinibFocal Adhesion SignallingXenograft Model Antitumor AssaysArticleAdrenal Cortex NeoplasmsGene Expression Regulation, NeoplasticMiceCell Line, TumorFocal Adhesion Kinase 1Antineoplastic Combined Chemotherapy ProtocolsHumansAnimalsFemale

Defactinib in Combination with Mitotane Can Be an Effective Treatment in Human Adrenocortical Carcinoma

FAIR Checklist

DataRank Breakdown

Authors (19)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)